本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crinetics Pharmaceuticals Inc.

84.86
+0.08000.09%
盤後84.69-0.1685-0.20%16:42 EDT
成交量:124.16萬
成交額:1.05億
市值:90.03億
市盈率:-16.87
高:84.86
開:84.83
低:84.78
收:84.78
52周最高:84.86
52周最低:30.00
股本:1.06億
流通股本:9,553.05萬
量比:0.34
換手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-5.0290
每股收益(LYR):-4.9500
淨資產收益率:-42.45%
總資產收益率:-26.28%
市淨率:7.55
市盈率(LYR):-17.14

資料載入中...

2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/06

重要事件披露

Form 8-K - Current report
2026/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors